Connect with us

News

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

gbafNews28

SHANGHAI, Sept. 28, 2020 /PRNewswire/ — InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a $147 million series D financing which has attracted participation of many top biopharmaceutical and healthcare venture capital funds. This round of investment was led by Hillhouse affiliate GL Ventures, followed by Qiming Venture Partners, Janchor, AIHC Capital, Matrix Partner China, Dyee Capital, E Fund Capital and other investors. The existing shareholders including Lilly Asia Venture, OrbiMed Asia, Pudong Innotek, AdvanTech Capital, and CMB International continued their support. China Renaissance was the exclusive financial advisor of this transaction.

Currently InventisBio has three drug products in the mid- to late-stage clinical development, and one new product just entered global phase I clinical study. Among them, D-0502 is an oral selective estrogen receptor degrader (SERD), which also acts as an estrogen receptor antagonist, with therapeutic potential for the treatment of hormone receptor positive breast cancer. Compared with other oral SERDs under clinical development worldwide, D-0502 has shown promising anti-tumor activity during phase 1 study with excellent bioavailability and tolerable safety profile. In addition, the company has independently developed a third-generation EGFR-T790M tyrosine kinase inhibitor BPI-D0316 and out-licensed China right to Betta Pharma. This product is currently in registration trials of first- and second-line treatment of EGFR-mutated non-small cell lung cancer patients and the trials are progressing smoothly.

Dr. Yaolin Wang, Chairman and CEO of InventisBio, said: "InventisBio is committed to developing first- and best-in-class innovative drugs for cancer and other major diseases. We are grateful and honored to have Hillhouse’s GL Ventures led this series D round and thankful to other top investment funds, as well as the continued support from the existing investors. This investment demonstrated the recognition of our strong pipeline and fully integrated innovative R&D platform by top healthcare investors. It also shows our strategic investors’ confidence in the future success of our company as a key player in the global pharmaceutical market."

Funds raised in this round will be mainly used to support the company’s current products into phase II clinical studies in China and the United States, including D-0502 trials in hormone receptor positive breast cancer and D-0120 trials in gout. This round will also support the company’s global clinical development of other new drugs, enable further expansion of the company’s product pipeline and team.

Michael Yi, co-chief investment officer of Hillhouse Capital and head of biomedicine and medical devices of Hillhouse’s GL Ventures, said: "As a small molecule innovative drug research and development company, InventisBio has an in-depth knowledge of small molecules’ structure activity relationship and integrated understanding and experience in the efficient and successful development of novel molecules. The founding members have more than 20 years of experience in drug discovery and development, thorough understanding of drug’s mechanism of action and selection of lead candidate for development. Since its establishment, InventisBio has balanced innovation and druggability, and has effectively developed multiple assets for diseases with unmet clinical needs. With four drug candidates in various clinical stages and two clinical registration trials ongoing, InventisBio has established its pipeline in two major therapeutic areas of oncology and metabolic diseases. In addition, the company has maintained a leading position in the drug development of similar products in China. We look forward to developing deep collaboration with InventisBio, advancing its drug discovery and clinical development to bring innovative drugs to the market faster to benefit more patients."

About InventisBio

InventisBio is a fast-growing innovative biotech company, co-founded by Dr. Yaolin Wang and other senior scientists. The company’s top management team members have an average of more than 20 years of experience in innovative drug discovery and development, and team management in multinational pharmaceutical companies such as Schering-Plough and Merck, and have contributed to the successful development of blockbuster drugs such as Keytruda and Temodar. The company focuses on the research and development of "best-in-class" and "first-in-class" innovative drugs to address unmet medical needs and to maximize clinical benefits for patients. Under the leadership of senior management team, the company has established a rich pipeline of competitive and proprietary small molecule drugs for the treatment of cancer and metabolic diseases.
http://www.inventisbio.com

About Hillhouse Affiliate GL Ventures

GL Ventures focuses on early-stage innovative companies in healthcare, software services, consumer Internet, emerging consumer brands and services. The GL Ventures team is passionate about partnering with visionary entrepreneurs to create industry leaders that stand the test of time. GL Ventures is the early stage affiliate of Hillhouse Capital, and we have been investing with innovators across the world since 2005. We were one of the earliest investors into some of the largest global companies today, including BeiGene, Zoom, Meituan, JD, Woowa Brothers and many more.

News

Mercury Derivatives Trading Selects Eventus Systems for Trade Surveillance

gbafNews28

Global Futures Proprietary Trading Firm Deploys Validus Platform

AUSTIN, Texas, Oct. 20, 2020 /PRNewswire/ — Eventus Systems, Inc., a multi-award winning global trade surveillance and risk management software platform provider, today announced that Mercury Derivatives Trading, a global futures proprietary trading firm with more than 500 traders operating in markets on six continents, has deployed Eventus’ Validus platform for trade surveillance.

Mercury Derivatives, part of the Hertshten Group, has adopted the cloud-based version of Validus on a T+1 basis for market surveillance, including the ability to identify and address a wide range of potential market manipulation behaviors.

Elad Hertshten, a senior member of the Hertshten Group, said: "For us, we find that one of the most important things to survive long-term in this industry is to be fully compliant. Trade surveillance is a key component of that, including complying with the exchanges in which we operate." 

Mercury Derivatives had been using a trade surveillance platform it had acquired, but it required significant resources to maintain, including an in-house developer. The firm planned to outsource next year but accelerated its plan after seeing Validus and participating in a custom demo. Hertshten said: "I’m a big believer in outsourcing what we’re not specialized in. The Validus technology is much more advanced than what we had. And we were particularly impressed with the people, hands-on support and professionalism. They delivered what they promised. Implementation was quick. The integration went smoothly, the communication has been great, and all timetables were met."

Amit Bhanwani, Head of Business Operations, said: "The Validus platform is quite intuitive, and we really like the open architecture and ability to build any type of automation into Validus on the basis of our requirements. The information captured in the platform is very granular in nature so if we want to see the data in a different format, we can drill down and add it to our main user interface. That gives me confidence that any form of customization is possible in this system."

Eventus CEO Travis Schwab said: "We’re delighted that Mercury Derivatives has put its confidence in us and look forward to a lasting relationship. Our focus from the beginning has been to offer clients not only superior, easy-to-use technology that meets the highest regulatory and firm standards, but also high-touch service they can’t find elsewhere."

Headquartered in Mauritius, the Hertshten Group also has operations in India, Israel, the UK and Canada.

About Eventus Systems

Eventus Systems is a leading global provider of multi-asset class trade surveillance and market risk solutions. Its powerful, award-winning Validus platform is easy to deploy, customize and operate across equities, options, futures, foreign exchange (FX), fixed income and digital asset markets. Validus is proven in the most complex, high-volume and real-time environments of tier-1 banks, broker-dealers, futures commission merchants (FCMs), proprietary trading groups, market centers, buy-side institutions, energy and commodity trading firms, and regulators. The company’s rapidly growing client base of more than 60 firms relies on Validus and Eventus’ responsive support and product development teams to overcome its most pressing regulatory challenges. For more, visit www.eventussystems.com

Logo – https://mma.prnasia.com/media2/635481/Eventus_Systems_Logo.jpg?p=medium600

Continue Reading

News

YOFC Presents at China International Information and Communications Exhibition 2020

gbafNews28

BEIJING, Oct. 20, 2020 /PRNewswire/ — Along with its product lineup and solutions designed to empower the deployment of 5G Internet, leading edge and intelligent applications in the future, Yangtze Optical Fibre and Cable Joint Stock Limited Company ("YOFC" or "the Company") (601869.SH, 06869.HK), a global leading optical fibre and cable provider, attended the China International Information and Communications Exhibition (PT Expo) 2020 organized by the Ministry of Industry and Information Technology of China.

YOFC's Exhibition Booth at China International Information and Communications Exhibition 2020
YOFC’s Exhibition Booth at China International Information and Communications Exhibition 2020

At the YOFC booth, the Company’s Space Division Multiplexing (SDM) solution for next-generation data centres took central stage. The solution was created based on new multi-core fibre technology, suitable for 800Gb and beyond systems, addressing the urgent demands of data centres for bigger capacity, longer transmission distance, high-density connections and low energy consumption. Also sharing the spotlight was the Company’s latest innovations in optical communications and materials.

New Products and Solutions Helping to Develop New Infrastructure Powered by Next-Gen Information Networks and 5G

YOFC’s robust industrial expertise and over 30-year exploration in ICT have enabled the Company to flesh out a product and solution roadmap that empowers the development of a new type of infrastructure enabled by next-gen information networks. With a global rollout of 5G on the horizon, YOFC showcased innovations covering five main categories to meet with pressing new infrastructure needs in the 5G era, which are 5G Series Products and Solutions, Power Grid Communication, Industrial Internet, Big Data Centers and Rail Transportation.

Building a robust 5G ecosystem requires new fibre, cable and optical modules with excellent quality and high efficiency. YOFC has developed solutions for various intelligent applications that will help accelerate a transition to 5G and the Internet of Everything. As part of the product lineup and solutions for 5G facilities, YOFC showcased MWDM Front-haul Solution,Cable Solution for Carrier Network and Optical Transceiver for 5G.

For the sophisticated and complex networks of ultra-high-voltage electricity transmission (UHV), To address these challenges, YOFC presented its latest products designed for a cleaner, safer, and more efficient modern energy system. Amongst these offerings, the G.654.E fibre features ultra-low attenuation with a large effective area, high-fibre-count OPGW cables, and icing monitoring system.

Green, flexible, fast and intelligent, these are some of the key features that define the future of big data centres. YOFC has developed integrated cabling solutions for data centres that feature high density, high performance, reliability and scalability. Products such as optical transceivers and all-in-one cabinets using edge-computing-integrated infrastructure, achieve more effective connectivity and reliable security for network transmission and information processing for data centres.

For rail transportation, YOFC has been leveraging its strength in cable manufacturing to develop numerous technologies for urban rail transit that achieve full bands, wide coverage and low attenuation, including 5G broadband radiation-mode leaky coaxial cable, distributed temperature system and distributed vibration monitoring system. These technologies accommodate the demands of urban rail systems for communication and promote the application of digital technologies in urban rail transportation.

Smart Ocean and Home Solutions

YOFC offers diversified products and solutions for smart tourism, smart communities, and smart education that provide a wide range of smart services, focuses on F5G all-optical network and transforming from "Fibre to the Home (FTTH)" to "Fibre to Everywhere" by expanding the application of the optical technology to all service scenarios. At the exhibition, YOFC presented its key technologies for the ocean and home.

  • Smart Ocean Solutions: YOFC showcased submarine optical cables to be used in various transoceanic communication systems applicable for both deep and shallow sea. The solution also features alternating (direct) current submarine (photoelectric composite) cables for power transmission;
  • Smart Home Solutions: including YOFC’s original BendRobust™ speciality bend-resistant fibre and self-developed high-efficiency photoelectric conversion chip which can maintain high performance and stability across various complex environments.

As information and communication technology (ICT) continues to revolutionize people’s way of life, YOFC continues its commitment to the core mission of establishing a smart link to create a better life, and serving global customers with innovation-led, high-performance and high-quality products; joining efforts with global partners to build a brighter future.

Related Stocks:
HongKong: 06869  
Shanghai: 601869 

Related Links:
https://en.yofc.com/

Related Links :

http://www.yofc.com

Continue Reading

News

IT Tech Packaging, Inc. Participated the ALL IN PRINT CHINA Exhibition

gbafNews28

BAODING, China, Oct. 20, 2020 /PRNewswire/ — IT Tech Packaging, Inc. (NYSE MKT: ITP) ("IT Tech Packaging" or "the Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced its CEO Mr. Zhenyong Liu together with its marketing team participated The 8th All In Print China Exhibition held in Shanghai City, the first comprehensive exhibition in printing and packaging business after the COVID-19 epidemic outbreak. The roaring trade released a strong signal of the positive recovery of the printing and packaging industry.

ITP partivipated The All In Print China
ITP partivipated The All In Print China

Mr. Zhenyong Liu, the CEO and Chairman of the Company commented: "the printing and packaging industry is improving as the domestic economy continues recovering, and so is the company. The two-day visit gave us a deep understanding about the latest materials, techniques and products. We will follow the industry trend and strive for a better performance with more advanced producing technology and product quality."

About IT Tech Packaging, Inc.

Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is located strategically close to the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE MKT since December 2009.

Safe Harbor Statements

This press release may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company’s public filings with the Securities and Exchange Commission, including the Company’s latest annual report on Form 10-K. All information provided in this press release speaks as of the date hereof. Except as otherwise required by law, the Company undertakes no obligation to update or revise its forward-looking statements.

For more information, please contact:

At the Company Email:
[email protected]
Tel: +86 0312 8698215

Related Links :

http://www.itpackaging.cn/

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News1 hour ago

Mercury Derivatives Trading Selects Eventus Systems for Trade Surveillance

Global Futures Proprietary Trading Firm Deploys Validus Platform AUSTIN, Texas, Oct. 20, 2020 /PRNewswire/ — Eventus Systems, Inc., a multi-award winning...

gbafNews28 gbafNews28
News1 hour ago

VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020

AUSTIN, Texas, Oct. 20, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company developing simple, easy...

gbafNews28 gbafNews28
News1 hour ago

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

INCHEON, South Korea, Oct. 20, 2020 /PRNewswire/ — Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona,...

gbafNews28 gbafNews28
News1 hour ago

CoinLock Announces Collaboration with Idoneus, IDON Token Available on Platform Today

– IDON luxury asset token to begin trading on the platform today. – IDON users can now enjoy more utility—like free hedging...

gbafNews28 gbafNews28
News1 hour ago

ATIF Holdings Limited Signs Letter of Intent to Acquire Illuminated Air Purification Solution Provider to Expand into Healthcare Technology Field

SHENZHEN, China, Oct. 20, 2020 /PRNewswire/ — ATIF Holdings Limited (Nasdaq: ATIF, the "Company"), a company providing business consulting and multimedia...

gbafNews28 gbafNews28
News1 hour ago

Over A Million Products On Sale During Banggood’s 11.11 Global Shopping Festival

GUANGZHOU, China, Oct. 20, 2020 /PRNewswire/ — Banggood, a leading cross-border e-commerce retailer, is offering exclusive discounts for its global...

gbafNews28 gbafNews28
News1 hour ago

Senmiao Technology Announces Signing of Framework Agreement with BYD to Purchase and Jointly Promote Electric Vehicles for Ride-Sharing

CHENGDU, China, Oct. 20, 2020 /PRNewswire/ — Senmiao Technology Limited ("Senmiao") (NASDAQ: AIHS), a provider of automobile transaction and related...

gbafNews28 gbafNews28
News1 hour ago

IT Tech Packaging, Inc. Participated the ALL IN PRINT CHINA Exhibition

BAODING, China, Oct. 20, 2020 /PRNewswire/ — IT Tech Packaging, Inc. (NYSE MKT: ITP) ("IT Tech Packaging" or "the Company"),...

gbafNews28 gbafNews28
News1 hour ago

YOFC Presents at China International Information and Communications Exhibition 2020

BEIJING, Oct. 20, 2020 /PRNewswire/ — Along with its product lineup and solutions designed to empower the deployment of 5G...

gbafNews28 gbafNews28
News1 hour ago

Aberdeen’s green stone coating expands into USA

TAIPEI, TAIWAN – Media OutReach – 20 October 2020 – The faux stone coating for buildings, a green product developed and...